psalexa

Global Respiratory Diagnostic and Monitoring Device Market (Size of $4,348.1 Million in 2015) to Witness 8.1% CAGR During 2016 – 2022

Published Date:   October 2016

The global respiratory diagnostic and monitoring device market is expected to progress at a CAGR of 8.1% during the forecast period. Some of the key factors driving the market growth are the surging geriatric population coupled with the high prevalence of chronic diseases; technological advancements; increasing cigarette consumption; and rising levels of air pollution across the globe. Besides, improving healthcare in developing countries is expected to create ample growth opportunities for the market players during the forecast period.

Among various end-user categories, home care is expected to witness the fastest growth in the respiratory diagnostic and monitoring device market, registering a CAGR of 9.1% during the forecast period. Based on product type, the market is categorized into pulse oximeter, spirometer, capnograph, gas analyzer, and others.

Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, chronic bronchitis, pulmonary edema, emphysema, lung cancer, and cystic fibrosis are generally diagnosed through medical tests and a physical examination. Various types of tests are performed to determine the functional status of the lungs and the effects of the disease on the respiratory system.

North America to Lead Respiratory Diagnostic and Monitoring Device Market

Globally, North America generated the highest revenue in the respiratory diagnostic and monitoring device market in 2015. The U.S. holds the largest share in the North American market. High prevalence of chronic diseases, increasing healthcare expenditure, and presence of key players are the major factors driving the growth of the market in the country. Moreover, it is further expected that the U.S. will continue leading the North American respiratory diagnostic and monitoring device market in the near future.

Some of the major players operating in the global respiratory diagnostic and monitoring device market are Masimo Corporation, General Electric Company, Hamilton Medical AG, Koninklijke Philips N.V., and Medtronic plc.

RESPIRATORY DIAGNOSTIC AND MONITORING DEVICE MARKET SEGMENTATION

Market Segmentation by Product Type

  • Pulse Oximeter
  • Spirometer
  • Capnograph
  • Gas Analyzer
  • Others

Market Segmentation by End User

  • Hospitals
  • Home Care
  • Others

Market Segmentation by Geography

  • North America Respiratory Diagnostic and Monitoring Device Market
    • By Product Type
    • By End User
    • By Country – U.S., Canada, and Rest of North America
      • U.S. respiratory diagnostic and monitoring device market
        • By product
        • By end user
      • Canada respiratory diagnostic and monitoring device market
        • By product
        • By end user
  • Europe Respiratory Diagnostic and Monitoring Device Market
    • By Product Type
    • By End User
    • By Country – Germany, U.K., France, Italy, Spain, and Rest of Europe
      • Germany respiratory diagnostic and monitoring device market
        • By product type
        • By end user
      • U.K. respiratory diagnostic and monitoring device market
        • By product type
        • By end user
      • France respiratory diagnostic and monitoring device market
        • By product type
        • By end user
  • Asia-Pacific (APAC) Respiratory Diagnostic and Monitoring Device Market
    • By Product Type
    • By End User
    • By Country – Japan, China, India, and Rest of APAC
      • Japan respiratory diagnostic and monitoring device market
        • By product type
        • By end user
      • China respiratory diagnostic and monitoring device market
        • By product type
        • By end user
      • India respiratory diagnostic and monitoring device market
        • By product type
        • By end user
  • Rest of the World (RoW) Respiratory Diagnostic and Monitoring Device Market
    • By Product Type
    • By End User